Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2018 · grant · Academic Research
EXTernal beam radiation to Eliminate Nominal metastatic Disease (EXTEND): A randomized phase II basket trial to assess local control of oligometastatic disease
Chad Tang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2018–2020 · research · R21
Collateral Deletions Expose Targetable Metabolic Vulnerabilities in the PTEN locus
Florian Muller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R35
EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS
Glen Traver Hart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R35
The molecular and genetic bases of diverse tissue repair responses in postembryonic Drosophila
Michael J Galko · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2024 · research · R01
Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application
Liang Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R21
Composition and temporal changes of the oral microbiome in head and neck cancer patients at high risk for oral mucositis
Cielito C Reyes-Gibby · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R35
EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS
Glen Traver Hart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
Jennifer A. Wargo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Role of Cul4A in Governing Th2-Type Tolerance
Roza Insafetdinovna Nurieva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2019 · research · R03
Study of the check point inhibitors with or without antifungals on the natural history of murine invasive pulmonary aspergillosis
Dimitrios P Kontoyiannis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2020 · fellowship · F32
SUPR peptides for tumor glycosylated MUC1 imaging
Brian Joseph Engel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic modulation of the phagocytosis axis as a novel glioblastoma immunotherapy
Betty Kim · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2026 · research · R01
Molecular basis of the NAADP-gated calcium release channel complexes - Equipment Supplement
Jiusheng Yan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2020 · research · R21
Co-operative roles for YAP1 and UCHL5 in cancer progression and therapy
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018 · grant · Academic Research
Mucosal vaccine formulations for targeted therapy of HPV cancers
Jagannadha Sastry · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2018–2023 · research · R37
Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma
Simona Colla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors, and Economic Implications
Ya-Chen Tina Shih · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2020 · research · R01
Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152
Qiang Shen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
Shulin Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Activating p53 for colorectal cancer prevention
Xiangwei Wu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
Stephanie S Watowich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R25
Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)
Prajnan Das · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018 · career development · Young Investigator Award
Microbiome Profile as a Predictive Biomarker for Cervical Cancer Response to Chemoradiation and Immunotherapy Treatment
Penny Fang · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · research · ASH Bridge Grant
ASH Bridge Grant 2018: Vahid Afshar-Kharghan
Vahid Afshar-Kharghan · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2018 · career development · Young Investigator Award
Identification of viral and immune biomarkers for metastasis and poor survival in penile squamous cell carcinoma
Jad Chahoud · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Remote monitoring of patient reported outcomes with Fitbit to enable longitudinal predictive modeling in prostate cancer
Andrew Laccetti · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · fellowship · Gianni Bonadonna Breast Cancer Research Fellowship
Role of the PI3K pathway in promoting immune evasion and resistance to systemic therapy in triple negative breast cancer
Clinton Yam · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · research · Neuroendocrine Tumor Research Foundation-AACR Grant
Next generation animal models to define therapies for neuroendocrine tumors
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2018 · research · Advanced Clinical Research Award
Understanding barriers and decreasing the time to chemotherapy in a vulnerable population: Pilot study of a targeted intervention
Mariana Chavez-Macgregor · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · training · ASH HONORS Award: Residents
ASH HONORS Award 2018: Yang Jiang
Yang Jiang · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2018 · career development · Young Investigator Award
Modulation of anti-tumor immune response in colorectal cancer through PI3K-AKT pathway inhibition.
Maliha Nusrat · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Career Development Award
Harnessing the Immune System in Neuroendocrine Tumors
Daniel Halperin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Global Oncology Young Investigator Award
Geonomic and Immunologic Profiling in Asian versus Western Extrahepatic Cholangiocarcinoma Patients
Reham Abdelwahab Hassan Ali · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Defining the function and targeting HIF-2 alpha in Acute Myeloid Leukemia
Paul Koller · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
A Phase I/Ib Pilot Study of Combined Trabectedin and Venetoclax in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK inhibitor
Paolo Strati · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Targeting DNA damage response via ATR inhibition to enhance PARP and PD-L1 blockade in small cell lung cancer.
Carl Gay · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2018–2026 · research · R01
Molecular basis of the NAADP-gated calcium release channel complexes
Jiusheng Yan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2032 · research · R35
Mesoscale and Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
John A. Tainer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
